Prognostic Factors for Ablation of Atrial Fibrillation
Launched by CHARLES UNIVERSITY, CZECH REPUBLIC · Jan 29, 2023
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to understand what factors help people maintain a normal heart rhythm after a treatment called catheter ablation for atrial fibrillation (AFib). AFib is a condition where the heart beats irregularly and can lead to serious complications. The study aims to identify certain characteristics or conditions that might improve the chances of staying in a normal rhythm after the procedure.
To participate in this trial, individuals must be diagnosed with atrial fibrillation and be between the ages of 65 and 74. It's important to note that participants will need to give informed consent, meaning they will have to understand and agree to the study before joining. As the trial is not yet recruiting, interested individuals will need to wait for it to start. Participants can expect to be part of a study that could provide valuable insights into improving heart health for those with atrial fibrillation.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • atrial fibrillation
- Exclusion Criteria:
- • absent of informed content
About Charles University, Czech Republic
Charles University, located in the Czech Republic, is a prestigious institution renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive academic expertise and state-of-the-art facilities to conduct innovative research that aims to improve patient outcomes and contribute to the global medical community. With a focus on ethical standards and rigorous scientific methodologies, Charles University collaborates with various stakeholders to explore new therapies and enhance healthcare practices, fostering a culture of excellence in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials